€150m Deal Signed to develop Next-Gen COVID-19 Vaccine GSK and Cure ...

avatar

€150m Deal Signed to develop Next-Gen COVID-19 Vaccine

GSK and CureVac are collaborating to develop vaccine against probable variants/ mutants of the corona virus which would be ready by 2022.

Source: LinkedIn

Posted via D.Buzz

ctp palnet zahm archon covid-19 actnearn bilpcoin neoxian
0
0
0.000
2 comments
avatar

Your current Rank (63) in the battle Arena of Holybread has granted you an Upvote of 21%

0
0
0.000
Reply